SCHEMBL7904340

SCHEMBL7904340

COc1ccc(S(=O)(=O)N2CC3C(C2)C3N=C=S)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
CYP2D6 P10635 2/20 0.60
CYP2C19 P33261 2/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2C9 P11712 1/20 0.60
PKM P14618 4/20 0.54
NPC1 O15118 1/20 0.54
PKLR P30613 1/20 0.54
RAB9A P51151 1/20 0.54
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 2/20 0.48
KDM4E B2RXH2 3/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
NAAA Q02083 2/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
KMT2A Q03164 1/20 0.46
GAA P10253 2/20 0.45
USP2 O75604 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7904572 0.85 PKM (0.47) ALDH1A1CYP2C19PKMHTTSMN1; SMN2
SCHEMBL7904534 0.82 PKM (0.45) ALDH1A1CYP2C19CYP3A4PKMPKLR
SCHEMBL7903086 0.82 CYP2C9 (0.44) ALDH1A1CYP2D6CYP2C9PKMRAB9A
SCHEMBL7906423 0.82 CYP2C9 (0.44) ALDH1A1CYP2D6CYP2C9PKMRAB9A
SCHEMBL31315853 0.71 PKM (1.00) ALDH1A1PKMNPC1PKLRRAB9A
SCHEMBL1722721 0.71 PKM (1.00) ALDH1A1PKMNPC1PKLRRAB9A
SCHEMBL1044915 0.69 HTT (0.96) ALDH1A1CYP2D6CYP2C19PKMNPC1
SCHEMBL7903110 0.68 MEN1 (0.51) SMN1; SMN2MAPTTSHRKMT2A
SCHEMBL4555472 0.67 HTT (1.00) ALDH1A1CYP2D6CYP2C19PKMNPC1
SCHEMBL8508293 0.67 HTT (1.00) ALDH1A1CYP2D6CYP2C19PKMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194438-B1 ANTITUMOR AGENTS; ANTICANCER AGENTS; FARNESYL-PROTEIN TRANSFERASE INHIBITOR PFIZER INC. 2001-02-27 US disclosed
EP-1006113-A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth Pfizer Products Inc. (US) 2000-06-07 EP disclosed